Rothia spp.: An unusual cause of infective endocarditis

Javier Martínez de Victoria Carazo, Antonio García-Chamón Boronat, Francisco Anguita Santos, Alberto Vázquez-Blanquiño, Andrés Luís Ruíz Sancho
{"title":"Rothia spp.: An unusual cause of infective endocarditis","authors":"Javier Martínez de Victoria Carazo,&nbsp;Antonio García-Chamón Boronat,&nbsp;Francisco Anguita Santos,&nbsp;Alberto Vázquez-Blanquiño,&nbsp;Andrés Luís Ruíz Sancho","doi":"10.1016/j.eimce.2026.503199","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div><em>Rothia</em> spp. are commensal organisms involved in serious infections such as infective endocarditis (IE). There is a significant lack of information regarding de clinical course and management of <em>Rothia</em> spp. IE in immunocompetent patients.</div></div><div><h3>Methods</h3><div>This study describes 11 cases of <em>Rothia</em> spp. bacteremia over a 10-year period in a secondary hospital, analyzing clinical, demographic, and microbiological data. True infection was defined based on clinical signs, microbiological criteria, and radiological evidence.</div></div><div><h3>Results</h3><div>Three cases (27.3%) were confirmed as true infections, all presenting as infective endocarditis. All three infections were caused by <em>Rothia mucilaginosa</em> in non-immunocompromised patients. Identified risk factors included type 2 diabetes, pre-existing valvular disease, prosthetic implants, and odontogenic foci. 100% of cases developed severe central nervous system complications. Total bacterial eradication without recurrence was achieved, and no acute valve surgery was required.</div></div><div><h3>Conclusions</h3><div><em>Rothia</em> spp. can cause true bacteremia and IE in non-immunocompromised patients. Time to positivity (TTP) and clinical correlation are fundamental to distinguish between true infection and contamination. Individualized shorter antibiotic regimens might be explored in selected cases, although conventional durations remain the standard due to the severity of complications.</div></div>","PeriodicalId":72916,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica (English ed.)","volume":"44 7","pages":"Article 503199"},"PeriodicalIF":0.0000,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Enfermedades infecciosas y microbiologia clinica (English ed.)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2529993X26001176","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Rothia spp. are commensal organisms involved in serious infections such as infective endocarditis (IE). There is a significant lack of information regarding de clinical course and management of Rothia spp. IE in immunocompetent patients.

Methods

This study describes 11 cases of Rothia spp. bacteremia over a 10-year period in a secondary hospital, analyzing clinical, demographic, and microbiological data. True infection was defined based on clinical signs, microbiological criteria, and radiological evidence.

Results

Three cases (27.3%) were confirmed as true infections, all presenting as infective endocarditis. All three infections were caused by Rothia mucilaginosa in non-immunocompromised patients. Identified risk factors included type 2 diabetes, pre-existing valvular disease, prosthetic implants, and odontogenic foci. 100% of cases developed severe central nervous system complications. Total bacterial eradication without recurrence was achieved, and no acute valve surgery was required.

Conclusions

Rothia spp. can cause true bacteremia and IE in non-immunocompromised patients. Time to positivity (TTP) and clinical correlation are fundamental to distinguish between true infection and contamination. Individualized shorter antibiotic regimens might be explored in selected cases, although conventional durations remain the standard due to the severity of complications.
罗氏菌属:感染性心内膜炎的一种罕见病因
罗氏菌属是与感染性心内膜炎(IE)等严重感染有关的共生生物。在免疫功能正常的患者中,关于罗氏杆菌的临床病程和管理的信息明显缺乏。方法对某二级医院10年间11例罗氏菌血症病例进行临床、人口统计学和微生物学分析。真正的感染是根据临床症状、微生物学标准和放射学证据来定义的。结果3例(27.3%)确诊为真感染,均表现为感染性心内膜炎。在非免疫功能低下的患者中,所有三种感染均由粘胶罗氏菌引起。确定的危险因素包括2型糖尿病、先前存在的瓣膜疾病、假体植入物和牙源性病灶。100%的病例出现严重的中枢神经系统并发症。完全细菌根除无复发,不需要急性瓣膜手术。结论罗氏杆菌可引起非免疫功能低下患者的真菌血症和IE。时间到阳性(TTP)和临床相关性是区分真正感染和污染的基础。虽然由于并发症的严重程度,传统的持续时间仍然是标准,但在选定的病例中,可能会探索个体化的较短的抗生素治疗方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书